Literature DB >> 7966525

Mechanisms of ethanol-drug-nutrition interactions.

C S Lieber1.   

Abstract

Mechanisms of the toxicologic manifestations of ethanol abuse are reviewed. Hepatotoxicity of ethanol results from alcohol dehydrogenase-mediated excessive hepatic generation of nicotinamide adenine dinucleotide and acetaldehyde. It is now recognized that acetaldehyde is also produced by an accessory (but inducible) pathway, the microsomal ethanol-oxidizing system, which involves a specific cytochrome P450. It generates oxygen radicals and activates many xenobiotics to toxic metabolites, thereby explaining the increased vulnerability of heavy drinkers to industrial solvents, anesthetics, commonly used drugs, over-the-counter medications and carcinogens. The contribution of gastric alcohol dehydrogenase to the first pass metabolism of ethanol and alcohol-drug interactions is now recognized. Alcohol also alters the degradation of key nutrients, thereby promoting deficiencies as well as toxic interactions with vitamin A and beta-carotene. Conversely, nutritional deficits may affect the toxicity of ethanol and acetaldehyde, as illustrated by the depletion in glutathione, ameliorated by S-adenosyl-L-methionine. Other supernutrients include polyenylphosphatidylcholine, shown to correct the alcohol-induced hepatic phosphatidylcholine depletion and to prevent alcoholic cirrhosis in non-human primates. Thus, a better understanding of the pathology induced by ethanol has now generated improved prospects for therapy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7966525     DOI: 10.3109/15563659409017974

Source DB:  PubMed          Journal:  J Toxicol Clin Toxicol        ISSN: 0731-3810


  15 in total

Review 1.  Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications.

Authors:  D Fleisher; C Li; Y Zhou; L H Pao; A Karim
Journal:  Clin Pharmacokinet       Date:  1999-03       Impact factor: 6.447

2.  Molecular cloning, expression and catalytic activity of a human AKR7 member of the aldo-keto reductase superfamily: evidence that the major 2-carboxybenzaldehyde reductase from human liver is a homologue of rat aflatoxin B1-aldehyde reductase.

Authors:  L S Ireland; D J Harrison; G E Neal; J D Hayes
Journal:  Biochem J       Date:  1998-05-15       Impact factor: 3.857

3.  Evaluation of community pharmacists' knowledge and awareness of food-drug interactions in Palestine.

Authors:  Asma Radwan; Anwar Sweileh; We'am Shraim; Amr Hroub; Josephean Elaraj; Naser Shraim
Journal:  Int J Clin Pharm       Date:  2018-05-02

4.  Alcohol consumption and risk of colorectal cancer in a cohort of Finnish men.

Authors:  S A Glynn; D Albanes; P Pietinen; C C Brown; M Rautalahti; J A Tangrea; P R Taylor; J Virtamo
Journal:  Cancer Causes Control       Date:  1996-03       Impact factor: 2.506

5.  Pharmacokinetic interaction of abacavir (1592U89) and ethanol in human immunodeficiency virus-infected adults.

Authors:  J A McDowell; G E Chittick; C P Stevens; K D Edwards; D S Stein
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

Review 6.  Pharmacokinetic interactions between alcohol and other drugs.

Authors:  A G Fraser
Journal:  Clin Pharmacokinet       Date:  1997-08       Impact factor: 6.447

7.  Distinct retinoid metabolic functions for alcohol dehydrogenase genes Adh1 and Adh4 in protection against vitamin A toxicity or deficiency revealed in double null mutant mice.

Authors:  Andrei Molotkov; Louise Deltour; Mario H Foglio; Arnold E Cuenca; Gregg Duester
Journal:  J Biol Chem       Date:  2002-02-08       Impact factor: 5.157

8.  Differential induction of ethanol-metabolizing CYP2E1 and nicotine-metabolizing CYP2B1/2 in rat liver by chronic nicotine treatment and voluntary ethanol intake.

Authors:  Jiang Yue; Jibran Khokhar; Sharon Miksys; Rachel F Tyndale
Journal:  Eur J Pharmacol       Date:  2009-03-13       Impact factor: 4.432

9.  Alcohol dehydrogenase-catalyzed in vitro oxidation of anandamide to N-arachidonoyl glycine, a lipid mediator: synthesis of N-acyl glycinals.

Authors:  Halikhedkar Aneetha; David K O'Dell; Bo Tan; J Michael Walker; Thomas D Hurley
Journal:  Bioorg Med Chem Lett       Date:  2008-11-01       Impact factor: 2.823

Review 10.  Engineered Animal Models Designed for Investigating Ethanol Metabolism, Toxicity and Cancer.

Authors:  Stephanie Marshall; Ying Chen; Surendra Singh; Pablo Berrios-Carcamo; Claire Heit; Nicholas Apostolopoulos; Jaya Prakash Golla; David C Thompson; Vasilis Vasiliou
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.